(19)
(11) EP 4 572 750 A2

(12)

(88) Date of publication A3:
11.04.2024

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23855605.4

(22) Date of filing: 15.08.2023
(51) International Patent Classification (IPC): 
A61K 31/18(2006.01)
A61K 31/015(2006.01)
A61K 31/03(2006.01)
A61K 31/352(2006.01)
A61K 31/025(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 309/14; A61P 35/00
(86) International application number:
PCT/US2023/072200
(87) International publication number:
WO 2024/040045 (22.02.2024 Gazette 2024/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 15.08.2022 US 202263398077 P

(71) Applicant: Atux Iskay LLC
Plainsboro, NJ 08536 (US)

(72) Inventor:
  • OHLMEYER, Michael
    Plainsboro, New Jersey 08536 (US)

(74) Representative: K&L Gates LLP 
Friedrichstraße 110 A
10117 Berlin
10117 Berlin (DE)

   


(54) 2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN SULFONIMIDAMIDES AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS